545 related articles for article (PubMed ID: 9434860)
21. The peroxynitrite pathway in development: phenytoin and benzo[a]pyrene embryopathies in inducible nitric oxide synthase knockout mice.
Kasapinovic S; McCallum GP; Wiley MJ; Wells PG
Free Radic Biol Med; 2004 Dec; 37(11):1703-11. PubMed ID: 15528029
[TBL] [Abstract][Full Text] [Related]
22. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
Miranda AF; Wiley MJ; Wells PG
Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268
[TBL] [Abstract][Full Text] [Related]
23. Enhanced NADPH oxidases and reactive oxygen species in the mechanism of methanol-initiated protein oxidation and embryopathies in vivo and in embryo culture.
Miller-Pinsler L; Sharma A; Wells PG
Arch Toxicol; 2016 Mar; 90(3):717-30. PubMed ID: 25726414
[TBL] [Abstract][Full Text] [Related]
24. Evidence for Ras-dependent signal transduction in phenytoin teratogenicity.
Winn LM; Wells PG
Toxicol Appl Pharmacol; 2002 Nov; 184(3):144-52. PubMed ID: 12460742
[TBL] [Abstract][Full Text] [Related]
25. Evidence for lipoxygenase-catalyzed bioactivation of phenytoin to a teratogenic reactive intermediate: in vitro studies using linoleic acid-dependent soybean lipoxygenase, and in vivo studies using pregnant CD-1 mice.
Yu WK; Wells PG
Toxicol Appl Pharmacol; 1995 Mar; 131(1):1-12. PubMed ID: 7878664
[TBL] [Abstract][Full Text] [Related]
26. Embryonic prostaglandin H synthase-2 (PHS-2) expression and benzo[a]pyrene teratogenicity in PHS-2 knockout mice.
Parman T; Wells PG
FASEB J; 2002 Jul; 16(9):1001-9. PubMed ID: 12087061
[TBL] [Abstract][Full Text] [Related]
27. Resistance of CD-1 and ogg1 DNA repair-deficient mice to thalidomide and hydrolysis product embryopathies in embryo culture.
Lee CJ; Gonçalves LL; Wells PG
Toxicol Sci; 2011 Jul; 122(1):146-56. PubMed ID: 21505090
[TBL] [Abstract][Full Text] [Related]
28. [Transplacental teratogenesis].
Grella PV
Acta Biomed Ateneo Parmense; 2000; 71 Suppl 1():467-72. PubMed ID: 11424790
[TBL] [Abstract][Full Text] [Related]
29. A role for glutathione, independent of oxidative stress, in the developmental toxicity of methanol.
Siu MT; Shapiro AM; Wiley MJ; Wells PG
Toxicol Appl Pharmacol; 2013 Dec; 273(3):508-15. PubMed ID: 24095963
[TBL] [Abstract][Full Text] [Related]
30. An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis.
Nicol CJ; Zielenski J; Tsui LC; Wells PG
FASEB J; 2000 Jan; 14(1):111-27. PubMed ID: 10627286
[TBL] [Abstract][Full Text] [Related]
31. Variable in vivo embryoprotective role for ataxia-telangiectasia-mutated against constitutive and phenytoin-enhanced oxidative stress in atm knockout mice.
Bhuller Y; Jeng W; Wells PG
Toxicol Sci; 2006 Sep; 93(1):146-55. PubMed ID: 16714389
[TBL] [Abstract][Full Text] [Related]
32. Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblasts.
Vienneau DS; DeBoni U; Wells PG
Cancer Res; 1995 Mar; 55(5):1045-51. PubMed ID: 7866987
[TBL] [Abstract][Full Text] [Related]
33. Phenytoin-initiated hydroxyl radical formation: characterization by enhanced salicylate hydroxylation.
Kim PM; Wells PG
Mol Pharmacol; 1996 Jan; 49(1):172-81. PubMed ID: 8569704
[TBL] [Abstract][Full Text] [Related]
34. Role of Cu/Zn-superoxide dismutase in xenobiotic activation. II. Biological effects resulting from the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
Li Y; Kuppusamy P; Zweir JL; Trush MA
Mol Pharmacol; 1996 Mar; 49(3):412-21. PubMed ID: 8643080
[TBL] [Abstract][Full Text] [Related]
35. Embryonic catalase protects against endogenous and phenytoin-enhanced DNA oxidation and embryopathies in acatalasemic and human catalase-expressing mice.
Abramov JP; Wells PG
FASEB J; 2011 Jul; 25(7):2188-200. PubMed ID: 21478259
[TBL] [Abstract][Full Text] [Related]
36. Peroxidase-dependent bioactivation and oxidation of DNA and protein in benzo[a]pyrene-initiated micronucleus formation.
Kim PM; DeBoni U; Wells PG
Free Radic Biol Med; 1997; 23(4):579-96. PubMed ID: 9215804
[TBL] [Abstract][Full Text] [Related]
37. Modulation of embryonic glutathione peroxidase activity and phenytoin teratogenicity by dietary deprivation of selenium in CD-1 mice.
Ozolins TR; Siksay DL; Wells PG
J Pharmacol Exp Ther; 1996 May; 277(2):945-53. PubMed ID: 8627577
[TBL] [Abstract][Full Text] [Related]
38. Embryoprotective role of endogenous catalase in acatalasemic and human catalase-expressing mouse embryos exposed in culture to developmental and phenytoin-enhanced oxidative stress.
Abramov JP; Wells PG
Toxicol Sci; 2011 Apr; 120(2):428-38. PubMed ID: 21252394
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandin H synthase-1-catalyzed bioactivation of neurotransmitters, their precursors, and metabolites: oxidative DNA damage and electron spin resonance spectroscopy studies.
Gonçalves LL; Ramkissoon A; Wells PG
Chem Res Toxicol; 2009 May; 22(5):842-52. PubMed ID: 19374330
[TBL] [Abstract][Full Text] [Related]
40. Embryonic catalase protects against ethanol embryopathies in acatalasemic mice and transgenic human catalase-expressing mice in embryo culture.
Miller-Pinsler L; Wells PG
Toxicol Appl Pharmacol; 2015 Sep; 287(3):232-9. PubMed ID: 26074427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
